.ElonMusk's neuralink needs more work before it's ready for clinical trials, says the US_FDA. The FDA's concerns include the potential for device wires to migrate to other parts of the brain and whether the device can be safely removed without damage.
Neuralink had its application for starting human testing rejected by the FDA in 2022, according to Reuters. The agency said Neuralink had to address dozens of issues before human testing would be allowed. These included safety concerns about the device's battery, the potential for device wires to migrate to other parts of the brain, and whether the device can be removed without damaging the brain.
Neuralink has not released details about its trial application, the rejection, or specifics on the agency's concerns. The rejection may have come about in part due to Musk's differing views on regulators, according to former staffers. The billionaire has been regularly critical of agencies such as the FDA and the Securities and Exchange Commission and has regularly attempted to evade their rules. He also ran the startup similarly to his other businesses, which may not have allowed the company to accommodate all relevant medical concerns.
The Department of Agriculture's Inspector General opened an investigation into Neuralink's experiments in early 2022 over allegations that the company had violated animal welfare laws.Over 20 current and former employees alleged that pressure from Musk to speed up development led to more failed experiments and animals being tested and killed. More than 1,500 animals are estimated to have been killed by the company following experiments since 2018, including 280 sheep, pigs, and monkeys.
The company was also sued by activists in Feb. 2022, who alleged that Musk's organization had tortured and mutilated monkeys while researching the subject.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Factbox: Elon Musk's missed deadlines for FDA approval of Neuralink brain-chip trialsSeveral times since 2019, billionaire Elon Musk has predicted his brain-chip company, Neuralink, would soon secure FDA approval for human trials. But the company's application was rejected in early 2022, Neuralink staffers told Reuters, and the company is still working through the agency's concerns over the safety of the experimental implant.
Read more »
FDA reportedly denied Neuralink's request to begin human trials of its brain implant | EngadgetAccording to Reuters, the FDA denied Neuralink's request to being human trials last year over concerns of safety arising from animal model testing..
Read more »
Factbox: Neuralink, other brain-chip makers face long road to FDA approvalNeuralink, founded in 2016, has yet to receive FDA approval to test its brain chip in humans. Other implant makers have spent years or decades on research to secure U.S. regulatory approvals.
Read more »
FDA will have 'empowered' human foods chiefThe FDA is launching a search for the newly created deputy commissioner for human foods, promising they'll have 'a clear line of authority' over the proposed human foods program.
Read more »
Regulators Reportedly Rejected Elon Musk's Application to Test Brain Chips in HumansUS regulators denied Elon Musk's Neuralink's application to start testing the company's brain chips in humans last year, Reuters reports.
Read more »
Flu and COVID combo shots won't come in time for this year, FDA official saysThe FDA's goal is to roll out the combo option by the following flu season.
Read more »